Totally Agree Paul.Sud already had a decent holding prior to...

Totally Agree Paul.

Sud already had a decent holding prior to exercising his options in September and had he had any doubts about any of our candidates
then he wouldn't have scrounged around and parted with over $8 million of his own cash to increase his holdings.

Dial the clock forward to today and what has changed regarding the core business and our drug candidates?

Positive TBI results
Positive OSA results
GAD pathway progression
The Acquisition of APIRX making IHL the holder of the most CBD patented candidates than any other globally.
More than $40 million in the bank to enable the Company to navigate and progress thru these trying times.
IMO the loyalty options exercise was always going to hurt the SP (at 35 cents) but a CR was always inevitable after the cancelled Nasdaq IPO.
The BOD looked to its shareholders for support in raising capital that it had depended on acquiring from the IPO.
Yes I was filthy that shares were being made available at almost half the SP at the time but at least it was structured to only be made
available to current shareholders.
Unfortunately the shorters stepped in and seized the opportunity knowing that the SP was destined to drop.
Almost overnight the stock went from having under 50,000 registered short positions to over 7 million. This has thwarted any possibility of
an SP recovery short term. Now there is less than 2 million short positions.
Throw in interest rate hikes, higher inflation globally, the Ukraine war and Chinas economic position which has effected all markets, our SP
is now at 22 cents.
The recovery will be a slow one but it will recover.

Sud has done a remarkable job at IHL and has been one of the key personnel in getting the Company where it is today however the baton
had been handed over quite some time back to the likes of Mark B , Paul L and the team.

GLTAH